Product Information

We offer a wide range of plasma-derived and recombinant therapies and pharmaceuticals for the treatment of bleeding disorders. We also provide a variety of products used in the hospital setting for critical care, for primary immunological disorders, and as a thrombolytic agent.

The information provided herein is solely for use by physicians and healthcare professionals in the United States. The products listed may not have been approved in other countries and may not be available everywhere.

Click on the following links for information about CSL Behring's two most recently approved U.S. products:

A fibrinogen concentrate for the treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency
A C1 esterase inhibitor (human) to treat acute abdominal or facial attacks of hereditary angioedema (HAE) in adult and adolescent patients

» Transplant Medicine
» Coagulation
» Critical Care & Immunology
» Alpha-1
» Inhibitors

Transplant Medicine

Cytogam^®

Cytomegalovirus Immune Globulin Intravenous (HUMAN) (CMV-IGIV)

Supply Update

Product Site Product Details
Full Prescribing Information for Cytogam^®

Coagulation

	Helixate^® FS Antihemophilic Factor (Recombinant) Formulated with Sucrose Product Site Product Details Full Prescribing Information for Helixate^® FS
	Humate-P^® Antihemophilic Factor/von Willebrand Factor Complex (Human), Dried, Pasteurized Product Site Product Details Full Prescribing Information for Humate-P^®
	Monoclate-P^® Antihemophilic Factor (Human) Factor VIII:C Pasteurized Monoclonal Antibody Purified Product Details Full Prescribing Information for Monoclate-P^®
	Mononine^® Coagulation Factor IX (Human) Monoclonal Antibody Purified Product Site Product Details Full Prescribing Information for Mononine^®
	RiaSTAP™ Freeze-dried fibrinogen (factor I) concentrate Product Site Product Details Full Prescribing Information
	Stimate^® (Desmopressin acetate) Nasal Spray, 1.5 mg/mL. How to purchase Stimate^® Product Site Product Details Full Prescribing Information for Stimate^®

Critical Care & Immunology

Critical Care

AlbuRx^® 5, AlbuRx^® 25

Albumin (Human) 5% Solution and 25% Solution

Product Details
Full Prescribing Information for AlbuRx^® 5
Full Prescribing Information for AlbuRx^® 25

Albuminar^® 25

Product Details
Full Prescribing Information for Albuminar^® 25

Immune Mediated Disorders

Privigen®

Immune Globulin Intravenous (Human) 10%
NEW Privigen^® is an intravenous immunoglobulin (IVIg) that was approved by the FDA in July 2007.
Warning: Immune Globulin Intravenous (Human) (IGIV) products have been reported to be associated with renal dysfunction, acute renal failure, osmotic nephrosis, and death. See boxed warning and the PRECAUTIONS and DOSAGE AND ADMINISTRATION section of full Prescribing information for important information intended to reduce the risk of acute renal failure.

Product Site Product Details
Full Prescribing Information for Privigen®

Carimune^® NF Nanofiltered

Immune Globulin Intravenous (Human)
Warning: Immune Globulin Intravenous (Human) (IGIV) products have been reported to be associated with renal dysfunction, acute renal failure, osmotic nephrosis, and death. See boxed warning and the PRECAUTIONS and DOSAGE AND ADMINISTRATION section of full Prescribing information for important information intended to reduce the risk of acute renal failure.

Product Details
Full Prescribing Information for Carimune^® NF Nanofiltered